Multiple studies, including our previous work, have reported downregulation of C9orf72 transcription and reduced C9orf72 protein levels in C9-ALS/FTD patient tissues [7, 8, 10–13], pointing to a potential role for haploinsufficiency in disease pathogenesis. This evidence concerns the gene C9 and frontotemporal dementia.